Ετικέτες

Παρασκευή 11 Αυγούστου 2017

Epithelioid Malignant Mesothelioma Metastatic to the Skin: A Case Report and Review of the Literature

Mesothelioma is a rare form of cancer arising from a monolayer of mesothelial cells that form the lining of the internal body cavities and organs, with the vast majority of cases arising from the pleura (65-80%), less commonly from the peritoneum (10-30%), and rarely from the pericardium and tunica vaginalis testis (1-2%).



http://ift.tt/2vXek4b

Immunohistochemistry reveals an increased proportion of MYC-positive cells in subcutaneous panniculitis-like T-cell lymphoma compared with lupus panniculitis

Background

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a malignant primary cutaneous T-cell lymphoma that shares significant clinical, histopathologic, and immunophenotypic overlap with lupus erythematosus panniculitis (LEP).

Methods

We performed immunohistochemistry for the MYC oncoprotein on 23 cases of SPTCL (one CD8 negative) and 12 cases of LEP to evaluate if there are quantitative or qualitative differences in protein expression of this marker in these entities.

Results

In SPTCL cases, the percentage of all cells that were c-Myc positive ranged from 0.8% to 16%, with a mean of 5.0% and a median of 4.4%. In contrast, in the LEP cases, the percentage of c-Myc positive cells in the cases ranged from 0.34% to 3.7%, averaged 1.4%, and the median was 0.8%. The difference between the means of these two diagnostic categories was statistically significant. Fluorescence in situ hybridization performed on 4 cases of SPTCL with a relatively high level of MYC immunohistochemical staining, however, failed to demonstrate evidence of MYC rearrangement or amplification.

Conclusions

Our work demonstrates that MYC expression levels differ between these two histologic mimics and suggests that this important oncoprotein may play a role in the pathogenesis of SPTCL.



http://ift.tt/2uxzqm1

Metabolic Dysfunction in Parkinson’s Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism

Publication date: July 2017
Source:Brain Research Bulletin, Volume 133
Author(s): Annadurai Anandhan, Maria S. Jacome, Shulei Lei, Pablo Hernandez-Franco, Aglaia Pappa, Mihalis I. Panayiotidis, Robert Powers, Rodrigo Franco
The loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and the accumulation of protein inclusions (Lewy bodies) are the pathological hallmarks of Parkinson's disease (PD). PD is triggered by genetic alterations, environmental/occupational exposures and aging. However, the exact molecular mechanisms linking these PD risk factors to neuronal dysfunction are still unclear. Alterations in redox homeostasis and bioenergetics (energy failure) are thought to be central components of neurodegeneration that contribute to the impairment of important homeostatic processes in dopaminergic cells such as protein quality control mechanisms, neurotransmitter release/metabolism, axonal transport of vesicles and cell survival. Importantly, both bioenergetics and redox homeostasis are coupled to neuro-glial central carbon metabolism. We and others have recently established a link between the alterations in central carbon metabolism induced by PD risk factors, redox homeostasis and bioenergetics and their contribution to the survival/death of dopaminergic cells. In this review, we focus on the link between metabolic dysfunction, energy failure and redox imbalance in PD, making an emphasis in the contribution of central carbon (glucose) metabolism. The evidence summarized here strongly supports the consideration of PD as a disorder of cell metabolism.



http://ift.tt/2vM0TEs

IFC (Ed. Board)

Publication date: July 2017
Source:Brain Research Bulletin, Volume 133





http://ift.tt/2vucaGA

PERK as a hub of multiple pathogenic pathways leading to memory deficits and neurodegeneration in Alzheimer’s disease

S03619230.gif

Publication date: Available online 10 August 2017
Source:Brain Research Bulletin
Author(s): Masuo Ohno
Cell signaling in response to an array of diverse stress stimuli converges on the phosphorylation of eukaryotic initiation factor-2α (eIF2α). In the brain, eIF2α is a hub for controlling learning and memory function and for maintaining neuronal integrity in health and disease. Among four eIF2α kinases, PERK is emerging as a key regulator for memory impairments and neurodegeneration in Alzheimer's disease (AD). Genetic and pharmacological manipulations of PERK-eIF2α signaling have revealed that the overactivation of this pathway is not a mere consequence of the neurodegenerative process but play critical roles in AD pathogenesis and the occurrence of memory deficits. This review provides an overview of recent progress in animal model studies, which demonstrate that dysregulated PERK accounts for memory deficits and neurodegeneration not only as a detrimental mediator downstream of β-amyloidosis and tauopathy but also as an important regulator upstream of both pathogenic mechanisms in AD. A therapeutic perspective is also discussed, in which interventions targeting the PERK-eIF2α pathway are expected to provide multiple beneficial outcomes in AD, including enhanced mnemonic function, neuroprotection and disease modification.



http://ift.tt/2vMkZhL

Vertical distribution of soil extractable organic C and N contents and total C and N stocks in 78-year-old tree plantations in subtropical Australia

Abstract

Few studies have focused on the effects of long-term forest plantations on the soil profile of carbon (C) and nitrogen (N) stocks. In this study, we selected 78-year-old tree plantations that included three coniferous tree species (i.e., slash pine, hoop pine and kauri pine) and a Eucalyptus species in subtropical Australia. We measured soil extractable organic C (EOC) and N (EON) contents and total C and N stocks under different tree species on the forest floor and along a soil profile to 100 cm depth. The results showed that Eucalyptus had significantly higher soil EOC contents (3.3 Mg ha−1) than the other tree species (EOC of 1.9–2.3 Mg ha−1) and had significantly higher EON (156 kg ha−1) contents than slash pine (107 kg ha−1). Eucalyptus had significantly higher soil C (58.9 Mg ha−1) and N (2.03 Mg ha−1) stocks than the other tree species (22.3–27.6 Mg C ha−1 and 0.71–1.23 Mg N ha−1) at 0–100 cm depth. There were no differences in soil C stocks at the 0–100 cm depth among the coniferous tree species. Forest floor C stocks had stronger effects on mineral soil total N stocks than fine root biomass, whereas fine root biomass exerted stronger effects on soil total C stocks at the 0–100 cm depth than forest floor C and N stocks. Our results addressed large differences in soil C and N stocks under different tree species, which can provide useful information for local forest management practices in this region.



http://ift.tt/2fymxFr

A fluorogenic native chemical ligation for assessing the role of distance in peptide-templated peptide ligation

Publication date: Available online 10 August 2017
Source:Bioorganic & Medicinal Chemistry
Author(s): Henrik Petszulat, Oliver Seitz
Protein-templated reactions have been used for fragment-based drug discovery as well as for covalent labeling, detection and manipulation of proteins. In spite of the growing interest in protein-templated reactions, little is known about the design criteria. Herein we present a systematic study on the effects of proximity in peptide-templated reactions. To facilitate reaction monitoring at low concentrations we developed a fluorogenic native chemical ligation that is based on the integration of a fluorescence quencher in the thiol leaving group. The reaction system provided up to 39-fold increases of emission from a fluorescein unit. By using templates based on coiled coils as models we investigated the effect of misalignments. The distance-reactivity pattern for remotely aligned peptides was remarkably different to reaction scenarios that involved seamlessly annealed peptides with overhanging functional groups.

Graphical abstract

image


http://ift.tt/2ux35f0

Synthesis, pH dependent, plasma and enzymatic stability of bergenin prodrugs for potential use against rheumatoid arthritis

Publication date: Available online 10 August 2017
Source:Bioorganic & Medicinal Chemistry
Author(s): Rohit Singh, Vikas Kumar, Sonali S. Bharate, Ram A. Vishwakarma
Bergenin is a unique C-glycoside natural product possessing anti-inflammatory and anti-arthritic activity. It is hydrophilic molecule and stable under acidic conditions however is unstable at neutral-basic pH conditions. The rate of degradation is directly proportional to the increase in pH which might be one of the reasons for its low oral bioavailability. Thus, herein our objective was to improve its stability using prodrug strategy. Various ester and ether prodrugs were synthesized and studied for lipophilicity, chemical stability and enzymatic hydrolysis in plasma/ esterase. The stability of synthesized prodrugs was evaluated in buffers at different pH, in biorelevant media such as SGF, SIF, rat plasma and in esterase enzyme. All prodrugs displayed significantly improved lipophilicity compared with bergenin, which was in accordance with the criteria of drug-like compounds. Acetyl ester 4a2 appeared to be the most promising prodrug as it remained stable at gastric/intestinal pH and was completely transformed to the parent compound bergenin in plasma as desired for an ideal prodrug. The data presented herein, will help in designing stable prodrugs of unstable molecules with desired physicochemical properties in structurally similar chemotypes.

Graphical abstract

image


http://ift.tt/2ux5iaj

Human Genome Editing: Science, Ethics, and Governance.

Genome editing is a powerful new tool for making precise alterations to an organism's genetic material. Recent scientific advances have made genome editing more efficient, precise, and flexible than ever before. These advances have spurred an explosion of interest from around the globe in the possible ways in which genome editing can improve human health. The speed at which these technologies are being developed and applied has led many policymakers and stakeholders to express concern about whether appropriate systems are in place to govern these technologies and how and when the public should be engaged in these decisions.

http://ift.tt/2ux1Ts1

Effects of antenatal diet and physical activity on maternal and fetal outcomes: individual patient data meta-analysis and health economic evaluation.

Diet and activity interventions in pregnancy reduce gestational weight gain, with no significant benefit for a composite of maternal and fetal outcomes, irrespective of maternal characteristics, and are not cost-effective

http://ift.tt/2vXaRT4

Developing a Methodological Research Program for Longitudinal Studies: Proceedings of a Workshop—in Brief.

One of the strategic objectives of the National Institute on Aging (NIA) is to "support the development of population-based data sets, especially from longitudinal studies, suitable for analysis of biological, behavioral, and social factors affecting health, well-being, and functional status through the life course." To contribute to that objective and to inform the development of a methodological research program for longitudinal studies, the Committee on National Statistics held a public workshop in June 2017. The discussion focused on challenges that are specific to the types of longitudinal studies supported by NIA and aimed to identify areas of methodological research that could be pursued in order to benefit from emerging methods, new techniques, or other opportunities to enhance the data and increase data collection efficiency. This publication summarizes the presentations and discussions from the workshop.

http://ift.tt/2vXux98

Vitamin D and symptoms of depression in overweight or obese adults: a cross-sectional study and randomized placebo-controlled trial

Publication date: Available online 10 August 2017
Source:The Journal of Steroid Biochemistry and Molecular Biology
Author(s): Aya Mousa, Negar Naderpoor, Maximilian P.J. de Courten, Barbora de Courten
Recent evidence suggests that vitamin D deficiency may contribute to increased risk of depression. However, previous studies are limited by variability in participant characteristics including vitamin D deficiency status and presence of existing diseases, use of low doses of vitamin D supplementation for short durations, and use of co-interventions or psychotropic drugs. We examined whether 25-hydroxyvitamin D (25(OH)D) concentrations were associated with symptoms of depression, as well as whether vitamin D supplementation reduced symptoms of depression in overweight or obese and vitamin D-deficient, but otherwise healthy adults.Cross-sectional analyses were performed on baseline data from 63 (39M/24F) overweight or obese (body mass index (BMI) ≥25kg/m2) and vitamin D-deficient (25(OH)D ≤50 nmol/l) adults (mean age=31.3±8.5), without clinical depression. Participants were randomized to either a bolus oral dose of 100,000 IU followed by 4,000 IU daily of cholecalciferol, or matching placebo for 16 weeks. Interventional analyses were performed on data from 48 participants (30M/18F) who completed the trial. We measured serum 25(OH)D concentrations; anthropometry: BMI, waist-to-hip ratio (WHR), % body fat (dual X-ray absorptiometry); and depressive symptoms using the Beck Depression Inventory (BDI) before and after intervention. Data on dietary vitamin D intake (3-day food record), physical activity (international physical activity questionnaire), and sun exposure habits were collected using questionnaires.At baseline, mean 25(OH)D concentration was 32.9±11.3 nmol/l and total BDI score was 6.6±6.3 (range=0–33). There were no associations between 25(OH)D concentrations and total BDI scores or BDI subscales (all p>0.1). After the 16-week intervention, 25(OH)D concentrations increased in the vitamin D group compared to placebo (56.0±20.8 versus 2.7±13.9 nmol/L, respectively; p <0.0001). Change in total BDI scores did not differ between vitamin D and placebo groups (−2.0±4.5 versus −1.5±2.9, respectively; p=0.7). There were no differences in BDI subscales between groups (both p>0.1). Results remained non-significant after adjusting for multiple covariates including sun exposure, physical activity, and dietary vitamin D intake (all p>0.1).Our findings suggest that vitamin D deficiency may not be related to increased risk of depression in individuals without clinically significant depression and that the use of vitamin D supplementation may not be warranted for reducing depressive symptoms in this population. Further large-scale studies are needed to establish whether vitamin D supplementation may be beneficial for improving depressive symptoms in other population groups, including in those with existing depressive or psychiatric disorders.



http://ift.tt/2fyLfWz

Meetings Calendar 2017

Rejuvenation Research , Vol. 0, No. 0.


http://ift.tt/2wP8E9p

Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers

Conditions:   Oesophageal Carcinoma;   Gastric Adenocarcinoma
Intervention:   Other: Questionnaire
Sponsors:   University Hospital, Lille;   University of Lille Nord de France
Recruiting - verified August 2017

http://ift.tt/2uNlvrg

Nivolumab Plus Ipilimumab in Thyroid Cancer

Condition:   Thyroid Cancer
Interventions:   Drug: Nivolumab;   Drug: Ipilimumab
Sponsors:   Dana-Farber Cancer Institute;   Bristol-Myers Squibb
Not yet recruiting - verified August 2017

http://ift.tt/2uuJKPE

TCR-engineered T Cells in NSCLC and HNSCC Patients (ACTengine)

Conditions:   Solid Tumor;   Cancer;   Head and Neck Squamous Cell Carcinoma;   Squamous Cell Non-small Cell Lung Cancer
Interventions:   Biological: IMA201 T-Cells;   Diagnostic Test: IMA201_Detect;   Diagnostic Test: ACT-HLA;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: Recombinant human interleukin-2
Sponsors:   Immatics US, Inc.;   M.D. Anderson Cancer Center
Not yet recruiting - verified August 2017

http://ift.tt/2uNCh9K

Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC

Condition:   Medullary Thyroid Carcinoma
Interventions:   Drug: 111In-CP04;   Drug: 111In-CP04 with co-administration of gelofusine/gelaspan
Sponsors:   Paola Anna Erba;   Jagiellonian University Medical College;   University Hospital Freiburg;   Medical University Innsbruck;   University Medical Centre Ljubljana;   NATIONAL CENTRE FOR NUCLEAR RESEARCH, Poland;   Erasmus Medical Center;   INRASTES, NCSR Demokritos, Athens, Greece
Recruiting - verified August 2017

http://ift.tt/2uvinVL

Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv SCCHN Who Failed Pembro Monotherapy or Experiencing SD

Condition:   Squamous Cell Carcinoma of the Head and Neck
Interventions:   Biological: Imprime PGG;   Drug: Pembrolizumab
Sponsors:   Biothera;   Merck Sharp & Dohme Corp.
Not yet recruiting - verified August 2017

http://ift.tt/2uMN6sB

A Study of DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung Cancer

Conditions:   Head and Neck Cancer;   NSCLC
Intervention:   Drug: DBPR112
Sponsor:   National Health Research Institutes, Taiwan
Recruiting - verified May 2017

http://ift.tt/2uvoeKu

The effects of 17β-estradiol on blood brain barrier integrity in the absence of the estrogen receptor alpha; an in-vitro model

S00651281.gif

Publication date: Available online 10 August 2017
Source:Acta Histochemica
Author(s): Serap Erdem Kuruca, Sabriye Karadenizli, Kadriye Akgun-Dar, Aysegul Kapucu, Zulal Kaptan, Gulay Uzum
The blood-brain barrier (BBB), which saves the brain from toxic substances, is formed by endothelial cells. It is mainly composed of tight junction (TJ) proteins existing between endothelial cells. Estrogen is an important regulatory hormone of BBB permeability. It protects the BBB before menopause, but may increase BBB permeability with aging. In addition, nitric oxide modulates BBB permeability. Alcohol impairs the integrity of the BBB with oxidants and inflammatory mediators such as iNOS. We investigated the effects of estrogen on BBB integrity in an in vitro BBB model created with ERα-free HUVEC (human umbilical vein endothelial-like cells) to mimics the menopausal period.In vitro BBB model is created with HUVEC/C6 (rat glioma cells) co-culture. The effect of 17β-estradiol on ethanol-induced BBB disruption and change/or increase of iNOS activity, which modulate BBB integrity, were evaluated. Inducibility and functionality of BBB were investigated using transendothelial electrical resistance (TEER) and the expression of proteins TJ proteins (occludin and claudin-1) and iNOS activity by immunostaining.Our results revealed that 17β-estradiol treatment before and after ethanol decrease expression of occludin and claudin-1 and value of TEER which are BBB disrupt indicators. In addition, ethanol and 17β-estradiol separately and pre- and post-ethanol 17β-estradiol treatment increased iNOS expression. Thus our study suggests caution in the use of 17β-estradiol after menopause because 17β-estradiol at this time may both increase the inflammatory process as well as damage the BBB. We think that beneficial effects of 17β-estradiol may be through ERα but it needs further studies.



http://ift.tt/2hRYHW4

Αναζήτηση αυτού του ιστολογίου